Radon indication registry for the assessment of pain reduction, increase of quality of life and improvement in body functionality throughout low-dose radon hyperthermia therapy
- Conditions
- on-inflammatory, degenerative diseases of the musculoskeletal system: ankylosing spondylitis, rheumatoid arthritis, back pain, osteoarthritis in hip and knee, fibromyalgia syndrome, psoriatic arthritisMusculoskeletal DiseasesAnkylosing spondylitis, Rheumatoid arthritis, unspecified, Coxarthrosis [arthrosis of hip], Gonarthrosis [arthrosis of knee], Fibromyalgia
- Registration Number
- ISRCTN67336967
- Lead Sponsor
- Gastein Research Institute
- Brief Summary
2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35922780/ Results from ankylosing spondylitis patients (added 11/10/2022) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/37361027/ Pain symptons in patients with rheumatic musculoskeletal diseases (added 01/08/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 5000
1. Age >25, <75 years
2. No radon therapy within the last year
3. BMI >18, <34 kg/m²
4. Being diagnosed one of the six possible indications (ankylosing spondylitis, rheumatoid arthritis, back pain, osteoarthritis in hip and knee, fibromyalgia syndrome, psoriasis arthritis)
5. Being able to attend any form of radon therapy performed in the Gastein Valley
1. Severe cardiovascular disease/arrhythmia
2. Severe kidney dysfunction/inflammatory kidney participation in the context of an autoimmune disease
3. Acute infections
4. Highly acute attack in chronic polyarthritis
5. Hyperthyroidism
6. Malignancy patients: last accomplished chemotherapy or immune therapy has taken place <1 year ago
7. Pregnancy
8. Alcohol and/or drug abuse
9. Lacking language skills
10. Incapability of filling out a questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method